Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.
Inserm Unit 271, Hôtel Dieu Hospital, Lyon, France. zoulim@lyon151.inserm.fr
F
F
Zoulim
C
C
Trépo
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D004259:DNA-Directed DNA Polymerase; D004195:Disease Models, Animal; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D009154:Mutation; D012194:RNA-Directed DNA Polymerase; D014779:Virus Replication
D000998:Antiviral Agents; D012194:RNA-Directed DNA Polymerase; D004259:DNA-Directed DNA Polymerase